UNION’s drug discovery platform

UNION’s drug discovery platform has demonstrated ability to achieve high hit-rates in the discovery of new chemical entities with anti-inflammatory and/or anti-microbial activity. Basically, UNION’s drug discovery platform is leveraging many years of structure-activity-relationship insights to synthesize new potent chemical entities with favorable safety profiles and a high degree of precision. In fact, 42% of the new chemical entities synthesized by UNIONs medchem platform were subsequently demonstrated to have anti-inflammatory properties with EC50 3x higher for efficacy than EC50 for cytotoxicity.


 

 

 

 

 

 

 

 

Back to Pipeline